Cargando…

Predicting Response to Antibody Drug Conjugates: A Focus on Antigens’ Targetability

Antibody-drug conjugates (ADCs) represent a cornerstone in the treatment of many cancers nowadays. ADCs fulfill their function by binding a target on tumor cell membrane to deliver a cytotoxic payload; in addition, those moieties capable of crossing cancer cell membranes can achieve near-by cells th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ascione, Liliana, Crimini, Edoardo, Trapani, Dario, Marra, Antonio, Criscitiello, Carmen, Curigliano, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	New Drug Development and Clinical Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628585/ https://www.ncbi.nlm.nih.gov/pubmed/37665782 http://dx.doi.org/10.1093/oncolo/oyad246

Ejemplares similares

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
por: Ascione, Liliana, et al.
Publicado: (2022)

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
por: Marra, Antonio, et al.
Publicado: (2020)

Antibody–drug conjugates in solid tumors: a look into novel targets
por: Criscitiello, Carmen, et al.
Publicado: (2021)

Antibody–Drug Conjugates for the Treatment of Breast Cancer
por: Corti, Chiara, et al.
Publicado: (2021)

Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)

Diabetes mellitus: Exploring the challenges in the drug development process
por: Vaz, Julius A., et al.
Publicado: (2012)

Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies
por: Al-Showbaki, Laith, et al.
Publicado: (2022)

A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors
por: Gan, Hui K., et al.
Publicado: (2021)

Expression of tumor-associated antigens in breast cancer subtypes
por: Curigliano, Giuseppe, et al.
Publicado: (2019)

Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021()
por: Trapani, Dario, et al.
Publicado: (2021)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

Preventing and Managing Toxicities of High-Dose Methotrexate
por: Howard, Scott C., et al.
Publicado: (2016)

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance
por: Ramsey, Laura B., et al.
Publicado: (2017)

A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction
por: Gong, Jun, et al.
Publicado: (2019)

Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations
por: Bardia, Aditya, et al.
Publicado: (2019)

Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise
por: Lestuzzi, Chiara, et al.
Publicado: (2022)

A Long‐Term Extension Study of Bevacizumab in Patients With Solid Tumors
por: Oza, Amit M., et al.
Publicado: (2021)

Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma
por: DeMaria, Peter Joseph, et al.
Publicado: (2021)

Personalized medicine: Striding from genes to medicines
por: Nair, Sunita R.
Publicado: (2010)

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: t(last) (Common)
por: Fisher, Dennis, et al.
Publicado: (2015)

Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations
por: Zeng, Yaohui, et al.
Publicado: (2017)

Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals
por: Darpo, Borje, et al.
Publicado: (2017)

Estimation of the Power of the Food Effect on QTc to Show Assay Sensitivity
por: Ferber, Georg, et al.
Publicado: (2017)

The Cardiovascular Effects of a Meal: J‐T(peak) and T(peak)‐T(end) Assessment and Further Insights Into the Physiological Effects
por: Täubel, Jörg, et al.
Publicado: (2019)

Model‐Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV Infusion
por: Cirincione, Brenda, et al.
Publicado: (2017)

Influence of Meals and Glycemic Changes on QT Interval Dynamics
por: Cirincione, Brenda, et al.
Publicado: (2017)

Epitope Mapping: The First Step in Developing Epitope-Based Vaccines
por: Gershoni, Jonathan M., et al.
Publicado: (2012)

Discordance Between Child‐Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

Biperiden Challenge Model in Healthy Elderly as Proof‐of‐Pharmacology Tool: A Randomized, Placebo‐Controlled Trial
por: Bakker, Charlotte, et al.
Publicado: (2021)

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Cook v. FDA and the importation and release of lethal injection drugs
por: Meyers, Nicholas
Publicado: (2014)

Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
por: Crimini, Edoardo, et al.
Publicado: (2022)

Executive action to combat the rise of drug-resistant bacteria: is agricultural antibiotic use sufficiently addressed?
por: Jooma, Sonya
Publicado: (2015)

Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices
por: Patel, Nisarg A.
Publicado: (2017)

MYOCRISIN
Publicado: (1941)

Peramivir for influenza
Publicado: (2019)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Guselkumab for plaque psoriasis
Publicado: (2019)

Durvalumab for urothelial carcinoma, non-small cell lung cancer
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n9sngcrufmqgm0khi8u3toql94